VBLT Share Price Performance
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
Vascular Biogenics Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
VBLT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Vascular Biogenics Ltd. Key Details
Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
- -0.21
- 96.47%
- -3,317.05%
- 0%
About VBLT
- Founded
- 2000
- Employees
- 7
- CEO
- WebsiteView website
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi’in, Israel.
